Clinical cancer trials run into obstacles
Posted Jan 29, 2014 7:17 am.
This article is more than 5 years old.
Seems researchers have come up against a major barrier in the battle against cancer.
New analysis suggests one of every 10 clinical trials for adults with cancer ends prematurely because researchers can’t get enough people to test new treatments.
Experts say contributing factors include money, logistics and the mistaken fear that people won’t get the best care if they join one of these experiments.
The study’s lead author says the inability to complete studies can doom a drug.
Add CityNews Calgary as a trusted source on Google to see more local stories from us.
